Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
351 hedge funds and large institutions have $4.17B invested in Amedisys in 2021 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 120 increasing their positions, 123 reducing their positions, and 80 closing their positions.
2% less repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 123
2.29% less ownership
Funds ownership: 89.01% → 86.72% (-2.3%)
6% less funds holding
Funds holding: 375 → 351 (-24)
26% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 80
32% less call options, than puts
Call options by funds: $35.1M | Put options by funds: $51.4M
41% less capital invested
Capital invested by funds: $7.06B → $4.17B (-$2.9B)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$93.5M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$81M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$67.5M |
| 4 |
D.E. Shaw & Co
New York
|
+$56.7M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$50.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$168M |
| 2 |
JP Morgan Chase
New York
|
-$92.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$81.7M |
| 4 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$70.9M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$67.4M |
AMED Hedge Fund Activity: Q3 2021 in Review
351 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2021, worth a combined $4.17B — down 41% from $7.06B a quarter earlier.
Sellers outnumbered buyers: 80 funds closed out of AMED and 59 opened new positions — a net loss of 21 holders — while 123 trimmed existing stakes and 120 added.
The largest buyer was Ameriprise, adding an estimated $93.5M. The largest seller was Wellington Management Group, cutting an estimated $168M.
- 351 institutional investors held Amedisys (AMED) as of Q3 2021, down from 375 in Q2 2021.
- Funds reported $4.17B of Amedisys stock for Q3 2021, down 41% quarter-over-quarter.
- 59 funds opened new Amedisys positions in Q3 2021 and 80 closed out, a net change of -21 holders.
- The largest Amedisys buyer in Q3 2021 was Ameriprise, an estimated $93.5M added.
- The largest Amedisys seller in Q3 2021 was Wellington Management Group, an estimated $168M sold.
Based on aggregated 13F filings for Q3 2021.